homoarginine has been researched along with Thromboembolism, Venous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beyer-Westendorf, J; Bode-Böger, SM; Eggebrecht, L; Konstantinides, S; Martens-Lobenhoffer, J; Nagler, M; Prochaska, J; Rodionov, RN; Wild, P | 1 |
1 other study(ies) available for homoarginine and Thromboembolism, Venous
| Article | Year |
|---|---|
Homoarginine and methylarginines independently predict long-term outcome in patients presenting with suspicion of venous thromboembolism.
Topics: Adult; Age Factors; Aged; Arginine; Body Mass Index; Female; Heart Rate; Homoarginine; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Sex Factors; Survival Rate; Venous Thromboembolism | 2021 |